These findings indicated that low circulating Nrg4 appeared to add to the risk of CVD independently of body fat and HOMA-IR, suggesting that circulating Nrg4 may protect against CVD via mechanisms independent of insulin resistance and obesity. The gene discussed is NRG4; the disease is obesity due to melanocortin 4 receptor deficiency.